5 – Quality (CMC) considerations
1 5 – Quality (CMC) considerations Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical Trials Celia Lourenco, PhD,
Download 5 – Quality (CMC) considerations
Information
Domain:
Source:
Link to this page:
Documents from same domain
ICH HARMONISED TRIPARTITE GUIDELINE
www.ich.orgGOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL INGREDIENTS ICH Harmonised Tripartite Guideline Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting
Final Concept Paper Q12: Technical and Regulatory ...
www.ich.orgFINAL Q12 Concept Paper Endorsed: 9 September 2014 -3- product lifecycle management. To date, the main emphasis has been on the implementation of
Q7 Implementation Working Group ICH Q7 …
www.ich.orgInternational Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Secretariat, Chemin des Mines 9, P.O. Box 195, 1211 Geneva 20, Switzerland
GUIDELINE FOR GOOD CLINICAL PRACTICE
www.ich.orgGUIDELINE FOR GOOD CLINICAL PRACTICE INTRODUCTION Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the
ICH HARMONISED GUIDELINE
www.ich.orgE6(R1) Document History First Codification History Date New Codification November 2005 E6 Approval by the Steering Committee under Step 2 and release for public consultation.
ICH HARMONISED GUIDELINE - ICH Official web …
www.ich.orginternational conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ich harmonised guideline guideline for elemental impurities
![[ICH E2F] [EXAMPLE DSUR – PHASE III …](/cache/preview/1/3/5/f/e/1/c/f/thumb-135fe1cf2cdb82799c462ad0ea089c48.jpg)
[ICH E2F] [EXAMPLE DSUR – PHASE III …
www.ich.orgfictional document for illustrative purposes only document date: 5 october 2010 [ich e2f] [example dsur – phase iii investigational drug] zb3579
ADDENDUM TO ICH E11: CLINICAL INVESTIGATION …
www.ich.org3 ICH HARMONISED GUIDELINE ADDENDUM TO ICH E11: CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS IN THE PEDIATRIC POPULATION E11 (R1) ICH Consensus Guideline Released for Adoption on 18 August 2017, at Step 4 of the ICH
M4Q Implementation Working Group Questions & …
www.ich.org1. Introduction This document is intended to provide additional guidance for the preparation of an application file in the CTD-Q format (see section 2: General Issues).
I ADDENDUM TO ICH E6(R1 ... - ICH Official web site
www.ich.orgi ICH HARMONISED GUIDELINE INTEGRATED ADDENDUM TO ICH E6(R1): GUIDELINE FOR GOOD CLINICAL PRACTICE ICH E6(R2) Draft ICH Consensus Guideline Released for Consultation on 11 June 2015, at Step 2 of the ICH Process
Related documents
THE NATIONAL TUBERCULOSIS AND LEPROSY …
www.who.int2 FOREWORD The publication of the third edition of the National Tuberculosis and Leprosy Programme NTLP) manual marks a big step forward because it underscores the Programme’s commitment to providing the latest knowledge and
CONTENTS
apps.who.intHealth Systems Profile- Oman Regional Health Systems Observatory- EMRO 1 CONTENTS FOREWORD.....3
Method Validation in Pharmaceutical Analysis
www.pharmaresearchlibrary.comEdited by Dr. Joachim Ermer sanofi-aventis Industriepark Hchst Build. G875 65926 Frankfurt Germany Dr. John H. McB. Miller European Directorate for the Quality
Revised National Tuberculosis Control Programme …
health.bih.nic.inRevised National Tuberculosis Control Programme DOTS-Plus Guidelines January 2010 Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Nirman
DRAFT GUIDANCE ON APPROVAL OF CLINICAL …
www.cdsco.nic.inguidelines on approval of clinical trial & new drugs effective date: page 1 of 71 draft guidance on approval of clinical trials & new drugs draft guidance
CENTRAL DRUGS STANDARD CONTROL …
www.cdsco.nic.incentral drugs standard control organisation directorate general of health services, ministry of health and family welfare government of india
DIRECTORATE OF REGISTRATION AND …
apps.who.intdirectorate of registration and regulatory affairs guidelines for registration of imported drug products in nigeria nafdac/rr/002/00 a. general 1.
Communicable Disease Control Manual Chapter 2 ...
www.bccdc.caTel 604.707.2548 . Fax 604.707.2515 . www.bccdc.ca . Communicable Disease Control Manual Chapter 2: Immunization Part 5 - Adverse Events Following
Related search queries
THE NATIONAL TUBERCULOSIS AND LEPROSY, The National Tuberculosis and Leprosy Programme, CONTENTS, Method Validation in Pharmaceutical Analysis, Directorate, Revised National Tuberculosis Control Programme, Guidelines, GUIDANCE ON APPROVAL OF CLINICAL, Guidance on approval of clinical trials & new, CENTRAL DRUGS STANDARD CONTROL, Central drugs standard control organisation directorate, Registration and regulatory affairs guidelines for registration, Drug, Control